GALNT7 and colorectal cancer: In MSS colorectal cancers, GALNT7 expression was associated with survival in TCGA MSS (n = 430; P = 0.0160; HR = 0.58; 95% CI, 0.37–0.90; Fig. 2D) and AC-ICAM MSS (n = 224; P = 0.0164; HR = 0.56; 95% CI, 0.34–0.90; Fig. 2E) but not in GSE39582 MSS (n = 405; P = 0.4297; HR = 0.87; 95% CI, 0.61–1.24; Fig. 2F).